Colorado's Shocking Hepatitis B Vaccine Recommendation: What the CDC Isn't Telling You!

Colorado health officials are standing firm in their recommendation for universal hepatitis B vaccinations for newborns, despite a recent policy shift by the federal government that has reversed decades of medical guidance. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) voted last week to narrow its recommendations, now advising the vaccine only for infants whose mothers are known to be positive for the virus or whose status is unknown.

The change has prompted the Colorado Department of Public Health and Environment (CDPHE) to take action. Next Wednesday, the department will ask the Colorado Board of Health to adopt the 2025 recommendations from the American Academy of Pediatrics, which continues to advocate for universal hepatitis B birth doses. This emergency rulemaking is essential for the swift implementation of the academy's recommendations, according to CDPHE spokesperson Hope Shuler.

Currently, Colorado maintains its requirement that children attending childcare or school receive the hepatitis B vaccine, and most insurance plans will cover the costs associated with the birth dose of the vaccine. The state has seen a remarkable 99% reduction in pediatric hepatitis B infections since the birth dose was first recommended in 1991. From 2001 to 2015, Colorado reported only 23 cases of perinatal hepatitis B, and no confirmed cases since 2016, according to CDPHE data.

"Colorado has spent decades building an effective system of maternal screening and universal birth dose vaccination that has nearly eliminated infant hepatitis B infections in our state,"

said Jill Hunsaker Ryan, executive director of the CDPHE. She emphasized the strong evidence supporting the vaccine's safety and effectiveness, urging both providers and families to recognize the ongoing recommendations for all newborns.

Dr. Ned Calonge, CDPHE's chief medical officer, echoed this sentiment, noting that the information available to providers is designed to help families understand the vaccine's well-documented benefits.

"We still strongly recommend it, it's still available, and it's still paid for,"

he stated. He encouraged parents to remain informed, emphasizing that the scientific consensus on the vaccine's effectiveness and safety remains unchanged.

The urgency of this recommendation stems from the substantially higher risk of chronic hepatitis B infections in newborns and children. Such infections can lead to severe liver diseases, including cirrhosis and liver cancer. The recent changes in federal recommendations, influenced in part by Health and Human Services Secretary Robert F. Kennedy Jr., who has been criticized for spreading vaccine misinformation, have raised concerns within the medical community.

Colorado Governor Jared Polis, a Democrat, reiterated the state's commitment to scientific evidence.

"Colorado will continue to follow the science and strongly support the hepatitis B birth dose as a safe, simple, and effective protection for every newborn, even as ACIP creates confusion for families,"

he stated. This declaration reflects a broader concern among health officials regarding misinformation and its potential impact on public health.

As the CDPHE prepares to reinforce the importance of the hepatitis B birth dose, it draws attention to the significant public health gains achieved over the past three decades. The state's proactive approach to maternal screening and vaccination has been instrumental in nearly eradicating infant hepatitis B infections, a success story that health officials are determined to maintain.

In light of shifting federal guidelines, local health authorities are emphasizing the importance of parental awareness and informed decision-making regarding vaccinations. As Colorado moves forward, the focus remains on ensuring that families have access to credible information and resources to protect the health of their newborns.